Podcast appearances and mentions of kevin fernando

Kevin Fernando, MBChB, BSC Hons (Med Sci), MSc Diabetes - The Many Faces of PBC: Recognising Opportunities to Optimise Identification and Intervention Across Diverse Patient Populations

Kevin Fernando, MBChB, BSC Hons (Med Sci), MSc Diabetes - The Many Faces of PBC: Recognising Opportunities to Optimise Identification and Intervention Across Diverse Patient Populations

Kevin Fernando, FRCGP, FRCP Edin., FAcadMEd - Simplified Strategies to Optimise Obesity Management for Primary Point of Contact Clinicians

Kevin Fernando, FRCGP, FRCP Edin., FAcadMEd - Simplified Strategies to Optimise Obesity Management for Primary Point of Contact Clinicians

Kevin Fernando, FRCGP, FRCP Edin., FAcadMEd - Simplified Strategies to Optimise Obesity Management for Primary Point of Contact Clinicians

Kevin Fernando, FRCGP, FRCP Edin., FAcadMEd - Simplified Strategies to Optimise Obesity Management for Primary Point of Contact Clinicians

Kevin Fernando, FRCGP, FRCP Edin., FAcadMEd - Simplified Strategies to Optimise Obesity Management for Primary Point of Contact Clinicians

Kevin Fernando, FRCGP, FRCP Edin., FAcadMEd - Simplified Strategies to Optimise Obesity Management for Primary Point of Contact Clinicians

Join our resident Business Ninja Andrew with Kevin Fernando, Head of Growth Marketing at Guusto as they talk about creating an amazing workplace culture where people feel appreciated, connected and inspired.  It's been estimated that up to 70% of U.S. workers are emotionally disconnected from their workplaces. The lack of recognition is certainly one reason. In an era of limited time, money, and energy, we need to focus on what actually works.At Guusto, they help HR Leaders build employee recognition programs to transform culture. This is the very reason why Guusto exists, to deeply understand customer problems and desires. They embrace feedback from colleagues as a valuable opportunity to improve and get to the best ideas. They want to contribute to an inclusive and equitable culture and respect diverse opinions.Guusto focuses on results rather than work completed, and are accountable for successes and failures. They care about colleagues and recognize their contributions, but aren't afraid to deliver constructive feedback to help them grow.Learn more about them at https://guusto.com/-----Do you want to be interviewed for your business?  Schedule time with us, and we'll create a podcast like this for your business:  https://www.WriteForMe.io/-----https://www.facebook.com/writeforme.iohttps://www.instagram.com/writeforme.io/https://twitter.com/writeformeiohttps://www.linkedin.com/company/writeforme/https://www.pinterest.com/andysteuer/Want to be interviewed on our Business Ninjas podcast? Schedule time with us now, and we'll make it happen right away! Check out WriteForMe, more than just a Content Agency! See the Faces Behind The Voices on our YouTube Channel!

In this episode, Dr Kevin Fernando and Dr Jim McMorran discuss the ongoing NHS-Galleri trial. The study, which is being conducted among 140,000 asymptomatic patients in England, will assess whether th

In this episode, Dr Kevin Fernando and Dr Jim McMorran discuss the ongoing NHS-Galleri trial. The study, which is being conducted among 140,000 asymptomatic patients in England, will assess whether the new Galleri blood test can assist in detecting cancer early when used alongside existing screening measures in the NHS. Kevin and Jim consider the sensitivity, specificity and positive predictive value of the test, reflect on how the test compares with other investigative measures for cancer and contemplate the key practical aspects primary care professionals should be aware of.

Despite the ongoing challenges of the COVID-19 pandemic, 2021 brought us many more significant developments in type 2 diabetes research. In our final episode of the year, join Dr Kevin Fernando to hear his highlights from 2021 and thoughts about the year ahead. Dr Fernando is a GP partner with a special interest in diabetes, and is Scottish Lead for the UK Primary Care Diabetes Society. For more free CME, go to diabetes.knowledgeintopractice.com, where you can see all past episodes of the podcast as well as other free CME resources. Follow us on Twitter (@dkipractice) or connect on LinkedIn. References: Butler J, et al. Empagliflozin, Health Status, and Quality of Life in Patients with Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial. Circulation. 2021 Nov 15. doi: 10.1161/CIRCULATIONAHA.121.057812. Epub ahead of print. Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021 Mar 18;384(11):989. doi: 10.1056/NEJMoa2032183. Epub 2021 Feb 10. Taylor R, et al. Intra-organ fat content during weight loss-induced remission of type 2 diabetes in people with normal or raised BMI. Abstract 110 presented at the 57th Annual Meeting of the European Association for the Study of Diabetes, 27 September – 1 October 2021, virtual. Diabetologia. 2021 Sep 64:1–380. Disclosures: Dr Kevin Fernando has no relevant disclosures to report at this time. This independent educational activity is supported by an educational grant from Novo Nordisk A/S. The educational content has been developed by Liberum IME in conjunction with an independent steering committee; Novo Nordisk A/S has had no influence on the content of this education.

In this episode, Dr Kevin Fernando considers the case of Juliana, a 43-year-old journalist who requests a cholesterol check because her father experienced a heart attack in his early 50s. She has no p

In this episode, Dr Kevin Fernando considers the case of Juliana, a 43-year-old journalist who requests a cholesterol check because her father experienced a heart attack in his early 50s. She has no past medical history of note. Her lipid profile returns as follows: total cholesterol (TC), 7.5 mmol/L; HDL-cholesterol, 1.4 mmol/L; triglycerides, 2.2 mmol/L; LDL-cholesterol, 2.9 mmol/L. What should we do next, and what do current guidelines recommend regarding the detection and management of familial hypercholesterolaemia (FH)?

In this episode, Dr Kevin Fernando discusses diagnostic and management tips – as well as pitfalls to avoid – related to subclinical hyperthyroidism. Fatima is a 71-year-old woman who presents in primary care with non-specific malaise and a past medical history of atrial fibrillation, ischaemic heart disease and osteoporosis. On examination, there is no evidence of thyroid swelling. Her blood tests reveal a suppressed thyroid-stimulating hormone (TSH), but normal free thyroxine (FT4) and free triiodothyronine (FT3). Given Fatima's comorbidities, what should we do next?

In this episode, Dr Kevin Fernando discusses diagnostic and management tips – as well as pitfalls to avoid – related to subclinical hyperthyroidism. Fatima is a 71-year-old woman who presents in primary care with non-specific malaise and a past medical history of atrial fibrillation, ischaemic heart disease and osteoporosis. On examination, there is no evidence of thyroid swelling. Her blood tests reveal a suppressed thyroid-stimulating hormone (TSH), but normal free thyroxine (FT4) and free triiodothyronine (FT3). Given Fatima's comorbidities, what should we do next?

The cultural shifts in the world around us are now primarily driven by millennials and Gen Z.Understanding these shifts along with those driven by the COVID-19 pandemic in how we create, curate and experience culture will help us understand the shifting habits and tastes of the world around us. A lot of these insights come to light in Spotify's Global Trends Report “Culture Next”. On part 1 of discussion on the insights, Varun is joined by musicians Hanita Bhambri and Kevin Fernando along with Arjun Kolady from Spotify to talk about the shifts in the music space and what they mean for the culture of tomorrow.Follow Arjun Kolady on Twitter: https://twitter.com/arjunkolady?s=09Follow Arjun Kolady on Instagram: https://instagram.com/arjunkolady?utm_medium=copy_linkFollow Hanita Bhambri on Instagram:https://instagram.com/hanitabhambri?utm_medium=copy_linkFollow Kevin Fernando on Instagram: https://instagram.com/thekevinfernando?utm_medium=copy_linkTalk to Varun Duggirala on Twitter and Instagram: @varunduggiYou can find Varun Duggirala on LinkedIn: https://www.linkedin.com/in/varun-duggirala-31090313You can listen to this show and other awesome shows on the IVM Podcasts app on Android: https://ivm.today/android or iOS: https://ivm.today/ios, or any other podcast app.

Following the last episode focusing on GLP-1 RAs, we are now turning to SLGT2 inhibitors. Which patients would benefit most from an SGLT2 inhibitor, and who should we avoid offering one? To help answer these questions, we're joined by Dr Kevin Fernando, GP Partner and Scottish Lead for the UK Primary Care Diabetes Society. For more free education, visit the DKIP website, follow us on Twitter (@dkipractice) or connect on LinkedIn. Funding statement: This independent educational activity is supported by an educational grant from Eli Lilly, Merck Sharp and Dohme Corp. and Novo Nordisk A/S. The educational content has been developed by Liberum IME in conjunction with an independent steering committee; the financial supporters have had no influence on the content of this education. Disclosures: Dr Kevin Fernando declares the following: Advisory Board Member - Lilly, Napp, Boehringer Ingelheim Speaker Honorarium - Lilly, Napp, Boehringer Ingelheim References: - Zinman B et al. N Engl J Med. 2015;373(22):2117-2128 [EMPA-REG OUTCOME]. - Neal B et al. N Engl J Med. 2017;377(7):644-657 [CANVAS]. - Wiviott SD et al. N Engl J Med. 2019;380(4):347-357 [DECLARE-TIMI 58]. - Cannon CP et al. N Engl J Med. 2020 Oct 8;383(15):1425-1435 [VERTIS-CV]. - Perkovic V et al. N Engl J Med. 2019;380(24):2295-2306 [CREDENCE]. - McGuire D et al. JAMA Cardiol. 2021; 6(2): 1–11 [CVOT meta-analysis]. - Heerspink H et al. N Engl J Med. 2020 Oct 8;383(15):1436-1446 [DAPA-CKD]. - Packer M et al. N Engl J Med. 2020 Oct 8;383(15):1413-1424 [EMPEROR-Reduced]. Funding statement: This independent educational activity is supported by an educational grant from Eli Lilly, Merck Sharp and Dohme Corp., and Novo Nordisk A/S. The educational content has been developed by Liberum IME in conjunction with an independent steering committee; the financial supporters have had no influence on the content of this education.

On this Monday edition of Wake Up Legendary, I talk with Kevin Fernando-a full-time, Canadian, online marketer. On today's show he explains his background, him and I discuss how to handles people's expectations, how people romanticize starting their own business and a whole lot more.

Dr Kevin Fernando explains why the thinking around gout needs to change, along with common questions in relation to its management in primary care. What lifestyle advice should be given? When should urate-lowering therapy be offered, and what options are available? For those with a history of gout, how can future episodes be avoided?

Dr Kevin Fernando explains why the thinking around gout needs to change, along with common questions in relation to its management in primary care. What lifestyle advice should be given? When should urate-lowering therapy be offered, and what options are available? For those with a history of gout, how can future episodes be avoided?

Dr Kevin Fernando provides a practical overview of the utility of sodium–glucose cotransporter 2 inhibitors, focusing on dosing, cardiovascular and renal safety and the management of adverse events, including dehydration and genital infections.

Dr Kevin Fernando provides a practical overview of the utility of sodium–glucose cotransporter 2 inhibitors, focusing on dosing, cardiovascular and renal safety and the management of adverse events, including dehydration and genital infections.

Have your notebooks at the ready as Dr Kevin Fernando rounds off 2019 with tips on topical oestrogen, mirtazapine prescribing, symptoms associated with withdrawal of varenicline, valvular atrial fibrillation and gout, among others.

Have your notebooks at the ready as Dr Kevin Fernando rounds off 2019 with tips on topical oestrogen, mirtazapine prescribing, symptoms associated with withdrawal of varenicline, valvular atrial fibrillation and gout, among others.

Dr Kevin Fernando considers the optimal use of these tests: can we reduce unecessary testing, unecessary referrals and primary care workload?

Dr Kevin Fernando considers the optimal use of these tests: can we reduce unecessary testing, unecessary referrals and primary care workload?

Dr Kevin Fernando summarises the key points for primary care from the NICE guideline update.

Dr Kevin Fernando summarises the key points for primary care from the NICE guideline update.

Dr Kevin Fernando discusses detection and management of the condition in primary care, including how presentation in children differs from that in adults.

Dr Kevin Fernando discusses detection and management of the condition in primary care, including how presentation in children differs from that in adults.

Dr Kevin Fernando takes us through brief case scenarios to illustrate diagnostic tips and pitfalls in primary care.

Dr Kevin Fernando takes us through brief case scenarios to illustrate diagnostic tips and pitfalls in primary care.